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Regulator of G-protein signaling 4 (RGS4), an intracellular modulator of G-protein coupled receptor
(GPCR)-mediated signaling, is regulated by multiple processes including palmitoylation and protea-
some degradation. We found that co-expression of DHHC acyltransferases (DHHC3 or DHHC7), but
not their acyltransferase-inactive mutants, increased expression levels of RGS4 but not its Cys2 to
Ser mutant (RGS4C2S). DHHC3 interacts with and palmitoylates RGS4 but not RGS4C2S in vivo. Palm-
itoylation prolongs the half-life of RGS4 by over 8-fold and palmitoylated RGS4 blocked a1A-adren-
ergic receptor-stimulated intracellular Ca2+ mobilization. Together, our ﬁndings revealed that DHHC
proteins could regulate GPCR-mediated signaling by increasing RGS4 stability.
Structured summary:
MINT-8049215: Rgs4 (uniprotkb:P49799) physically interacts (MI:0915) with DHHC3 (uniprotkb:Q8R173)
by anti-tag coimmunoprecipitation (MI:0007)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The basic unit of a G-protein coupled receptor (GPCR) signaling
system contains four major components: receptor, G-protein,
effector and regulator of G-protein signaling (RGS) protein [1].
G-proteins, classiﬁed into Gs, Gi, Gq and G12 subfamilies, stimulate
intracellular signal proteins (effectors) when GTP binds to the
G-protein in response to ligand-activation of GPCRs. Signaling ends
when the G-protein hydrolyzes the bound GTP. RGS proteins in-
crease GTP hydrolysis rates of G-proteins up to 1000-fold, thus pro-
foundly inhibiting downstream consequences of GPCR activation.
Regulator of G-protein signaling 4 (RGS4) regulates signaling
mediated by GPCR coupled to Gi and Gq, and plays an important
role in regulation of the cardiovascular [2] and central nervous
systems [3] as well as tumorigenesis [4]. We reported that
RGS4 down-regulation in breast cancer cells is due to protea-
some degradation, and that proteasome blockade increased
RGS4 protein to levels that markedly inhibit breast cancer met-
astatic abilities [5]. Interestingly, RGS4 is not intrinsically unsta-chemical Societies. Published by E
RGS4, regulator of G-protein
harmacology, Creighton Uni-
nia Plaza, Omaha, NE 68178,ble, but is made unstable by N-arginylation [6,7] at the oxidized
N-terminal Cys (Cys2) [8] and then ubiquitinated and degraded
by proteasomes [6,9]. Thus, identiﬁcation of mechanisms under-
lying the regulation of oxidation-sensitive proteasome degrada-
tion of RGS4 is important.
RGS4 is also known to be palmitoylated, a reversible thioester
attachment of palmitate to Cys in a protein. Previous studies dem-
onstrated that the primary palmitoylation site of RGS4 was Cys2
[10,11]. Since oxidation of Cys2 is critical for RGS4 degradation
[8], it would be important to determine whether palmitoylation
regulates RGS4 protein stability.
Palmitoyl acyltransferases are integral membrane proteins with
a conserved DHHC (Asp-His-His-Cys) motif, and are largely local-
ized to Golgi [12]. The DHHC motif is crucial for enzyme activity
since mutation of Cys to Ser eliminates palmitoyltransferase activ-
ity [13]. A recent study demonstrated that DHHC3 and DHHC7 can
palmitoylate Ga to control Ga localization to the plasma mem-
brane, thus regulating GPCR signaling [13]. In the present study,
we sought to determine if DHHC proteins palmitoylate RGS4 and
how this impacts RGS4 stability given the convergence of these
processes on the Cys2 residue. Our data are the ﬁrst to show that
DHHC3 and DHHC7 are capable of palmitoylating RGS4 in vivo,
which prolongs RGS4 half-life by interfering with its proteasome
degradation, thus attenuating a1A-adrenergic receptor (a1A-AR)-
stimulated intracellular Ca2+ mobilization.lsevier B.V. All rights reserved.
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2.1. Cell lines and reagents
HEK293 cells and MDA-MB-231 breast cancer cells were from
American Type Culture Collection, and maintained in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) with 10% fetal bovine serum
(FBS, Invitrogen). Primary antibodies include mouse anti-HA (Cov-
ance), rabbit anti-Myc (ABM), and goat anti-b-actin (Santa Cruz
Biotechnology). Hydroxylamine, 2-bromopalmitate (2-BP), dithio-
threitol (DTT), cycloheximide, and MG132 were from Sigma–Al-
drich. 17-Octadecynoic acid (17-ODYA) was from Cayman
Chemical Company.
2.2. Western blot analysis
Proteins were extracted from cells using 1 radioimmunopre-
cipitation assay lysis buffer (RIPA; Santa Cruz), subjected to 12%
SDS–PAGE and transferred to Immobilon-FL membranes (Milli-
pore). RGS4 was detected by its HA-tag while DHHC3 and DHHC7
were detected by their Myc-tags. IRDye700- or IRDye800-labeled
secondary antibodies were used for protein band detection by a
LI-COR Odyssey imaging system (LI-COR Biosciences).
2.3. 2-BP, DTT, and hydroxylamine treatment
HEK293 cells were transfected with RGS4 and DHHC3 for 30 h
and then were treated without or with 2-BP (100 lM) for 4 h be-
fore extracting protein with RIPA buffer. For DTT or hydroxylamine
treatment, cell lysate (30 lg) was incubated with DTT (200 lM),
0.5 M hydroxylamine (pH 7.0) or 0.5 M Tris–HCl (pH 7.0) at room
temperature for 1 h, respectively. The mixtures were then analyzed
by Western blot.
2.4. Hypoxia treatment and RGS4 degradation analysis [14]
Hypoxic conditions were established by evacuating oxygen from
a sealed chamberwith 5% CO2 and 95% N2. HEK293 cells transfected
with RGS4 or RGS4 Cys2 to Ser mutant (RGS4C2S) with or without
DHHC3 were cultured under hypoxia for 24 h to accumulate RGS4
protein. Then, the cellswere culturedundernomoxia in thepresence
of cycloheximide (100 lM). The disappearance of the accumulated
RGS4 protein pool was followed over time byWestern blot.
2.5. Detection of palmitoylated RGS4 using Cu(I)-catalyzed azide-
alkyne cycloaddition reaction (click chemistry)
HEK293 cells co-transfected with GFP-tagged DHHC3 and HA-
tagged RGS4 were cultured in media containing 5% charcoal-Fig. 1. Cys2 is critical for oxidation-sensitive proteasome degradation of RGS4 protein
plasmids encoding HA-tagged WT RGS4 or RGS4C2S mutant. Cells under hypoxia (+) or n
cell lysate were subjected to Western blot analysis with anti-HA and anti-b-actin antibostripped FBS for 24 h. The media was changed to serum-free DMEM
for 1 h and then labeled with the lipid 17-ODYA (100 lM in DMEM
and 1% fatty-acid free BSA) for 8 h. Cells were lysed with buffer
(50 mM Tris–HCl, pH7.4, 150 mM NaCl, 2% Triton X-100, protease
inhibitors). RGS4 was immunoprecipitated using anti-HA afﬁnity
agarose beads and eluted with 200 lg/ml HA peptide (Sigma–
Aldrich).
Octadecynoylated RGS4 protein in the immunoprecipitates
was linked to biotin-azide reporter groups via click chemistry
[15]. Samples were analyzed by Western blot using anti-HA anti-
body to detect HA-tagged RGS4 and streptavidin-IRDye800 (LI-
COR) to detect 17-ODYA labeled proteins via the attached biotin.
2.6. Co-immunoprecipitation assay
Myc-tagged DHHC3 was co-transfected with control vector, HA-
tagged RGS4 or RGS4C2S mutant into HEK293 cells. After 30 h, cell
lysates were immunoprecipitated with anti-HA afﬁnity agarose
beads. The immunoprecipitate was subjected to Western blot anal-
ysis for RGS4 and DHHC3.
2.7. Measurement of intracellular Ca2+ in HEK293 cells expressing a1A-
AR
HEK293 cells were stably transfected with mouse a1A-AR and
a1A-AR expression was veriﬁed with [3H]prazosin, as described
[16]. Intracellular Ca2+ was measured using the ﬂuorescent Ca2+
indicator Fluo-4. Fluorescence of cell suspensions (1  106 cells)
were measured on a Varian Cary Eclipse ﬂuorescence spectrometer
at 30 C using 485 nm excitation/515 nm emission. Maximum ﬂuo-
rescence was obtained with the calcium ionophore A23187 (2 lM).
Changes in intracellular Ca2+ were quantiﬁed by the ratio of phen-
ylephrine-induced peak ﬂuorescence vs. the maximum
ﬂuorescence.
3. Results and discussion
3.1. Cys2 is critical for oxidation-sensitive proteasome degradation of
RGS4 in cells
Breast cancer MDA-MB-231 cells have very low levels of endog-
enous RGS4 because of rapid proteasome degradation [5]. As
shown in Fig. 1A, MDA-MB-231 cells transfected with C-terminal
HA-tagged wild-type (WT) RGS4 also have very low levels of re-
combinant RGS4 unless grown under hypoxic conditions, when
RGS4 levels approximate those seen in the presence of the protea-
some inhibitor MG132. Mutating the Cys2 residue to Ser in RGS4
(RGS4C2S) eliminates susceptibility to oxidation such that RGS4
levels are high and similar during normoxia, hypoxia orin MDA-MB-231 cells (A) and HEK293 cells (B). Cells were transfected with 1 lg
omoxia () for 24 h were treated without or with 20 lM MG132 for 4 h. Proteins in
dies. Images shown are representatives of four separate experiments.
Fig. 2. Co-expression of active DHHC proteins increases expression levels of RGS4 but not RGS4C2S mutant. HEK293 cells were transfected with HA-tagged WT RGS4 or
RGS4C2S mutant in the absence or presence of Myc-tagged DHHC3, DHHC7 or their inactive C157S or C160S mutants. Proteins in cell lysate were analyzed by Western blot
using anti-HA, anti-Myc and anti-b-actin antibodies. Images shown are representatives of three separate experiments. (A). Co-expression of DHHC3 or DHHC7 only caused
WT RGS4 to accumulate in cells and migrate more rapidly during electrophoresis (B). Acyltransferase activity is critical for DHHC3 and DHHC7 to modulate RGS4.
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to MDA-MB-231 cells since similar results are seen in HEK293
cells. Thus, we conﬁrmed that the Cys2 residue is critical for oxida-
tion-sensitive proteasome degradation of RGS4 in cells [8].
3.2. Co-expression of active DHHC proteins increases expression levels
of RGS4 but not RGS4C2S mutant
The Cys2 residue of RGS4 also is the primary target for palmi-
toylation [10,11]. We investigated whether palmitoylation affectsFig. 3. DHHC3 palmitoylates RGS4 in HEK293 cells. Cell lysates were analyzed by W
increased RGS4 protein in a dose-dependent manner, which was blocked by 2-BP (100 l
RGS4. (C). HEK293 cells co-transfected with GFP-tagged DHHC3 and RGS4 or RG
immunoprecipitated and biotin labeled. Samples were treated with Tris–HCl (lanes 1–
HA antibody and streptavidin-IRDye800. (D). DHHC3 forms complex with RGS4 but not
(upper panel). HA-tagged RGS4, RGS4C2S, and associated DHHC3-Myc were immunopre
anti-HA and anti-Myc antibodies, respectively (lower panel).RGS4 degradation. Palmitoylation of RGS4 in vivo has been shown
in mammalian cells, but the acyltransferase for RGS4 palmitoyla-
tion is unknown. Recently, a family of acyltransferases character-
ized by a DHHC domain has been identiﬁed as enzymes for
protein palmitoylation [17]. Fig. 2A shows the effects of Myc-
tagged DHHC3 or DHHC7 expression on co-expressed HA-tagged
RGS4 or RGS4C2S mutant in HEK293 cells. For WT RGS4 (left),
expression of DHHC3 or DHHC7 led to large increases in RGS4 pro-
tein. In contrast, RGS4C2S protein is readily detected, and there
was no effect of DHHC3 or DHHC7 expression on its levels (right).estern blot. Images are representatives of 3–6 separate experiments. (A). DHHC3
M). (B). DTT or hydroxylamine reversed DHHC3-induced increase in the mobility of
S4C2S were metabolically labeled with 17-ODYA. RGS4 and RGS4C2S were
3) or hydroxylamine (lanes 4–6) for 1 h prior to Western blot analysis using anti-
RGS4C2S in HEK293 cells. Expression of DHHC3-Myc was analyzed by Western blot
cipitated using anti-HA afﬁnity agarose beads and detected by Western blot using
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reveals that co-expression of DHHC3 or DHHC7 causes RGS4 but
not RGS4C2S mutant protein to migrate more rapidly during elec-
trophoresis (lanes 2 and 3 vs. lanes 5 and 6).
The C157S mutation of DHHC3 or the C160S mutation of
DHHC7 renders these proteins unable to palmitoylate [13]. As
shown in Fig. 2B, WT Myc-tagged DHHC3 or DHHC7 maintained
RGS4 protein levels and the increased rate of RGS4 band migration
in comparison to the acyltransferase-inactive DHHC mutants. This
suggests that the effects of DHHC proteins on RGS4 were probably
caused by palmitoylation.
3.3. DHHC3 palmitoylates RGS4 in HEK293 cells
Fig. 3A shows DHHC3 dose effects on HA-tagged RGS4 band
intensity and mobility on SDS–PAGE, effects that can be
antagonized by treatment of cells for 4 h with 2-BP, a competitive
inhibitor of palmitoylation. We also treated protein from DHHC3-
transfected cells with DTT or hydroxylamine to cleave the thioesterFig. 4. Palmitoylation protects RGS4 from oxidation-sensitive degradation. HEK293 cells
for 24 h and then transferred to normoxia in the presence of cycloheximide (100 lM). Ox
over time by Western blot assays. (A). Representative Western blot. MG132 blocked
independent experiments. RGS4 protein was quantiﬁed by densitometry and initial opt
Fig. 5. Palmitoylated RGS4 attenuates a1A-AR-stimulated intracellular Ca2+ mobilizatio
intracellular Ca2+ were quantiﬁed by the ratio of phenylephrine-induced peak ﬂuorescen
concentration–response curve in the absence (Control) or presence of prazosin (1 lM) (n
elevation in intracellular Ca2+. Data are typical of three experiments.bond of palmitoylated proteins. As shown in Fig. 3B, DTT or
hydroxylamine reduces mobility of the prominent faster migrating
RGS4 band (lane 3 vs. lanes 1 and 2) to the same position as the
RGS4C2S mutant (lane 4). This suggests that the mobility shift of
RGS4 was probably due to palmitoylation.
Protein palmitoylation has historically been detected by
incorporation of radiolabeled palmitate, but acetylene-fatty acids
such as 17-ODYA have recently been shown to function as a
metabolically incorporated probe for proﬁling protein palmitoy-
lation in mammalian cells [15]. As shown in Fig. 3C, click chem-
istry-detected 17-ODYA incorporation into RGS4 was entirely
dependent on Cys2 since this band was eliminated by the C2S
mutation (lane 3 vs. lane 2), and by hydroxylamine (lane 5 vs.
lane 2).
Co-immunoprecipitation of Myc-tagged DHHC3 with HA-
tagged RGS4 was performed using anti-HA antibody-agarose
beads. Data in Fig. 3D indicates that DHHC3 interacts with RGS4,
but not RGS4C2S, again showing the importance of the Cys2 resi-
due for DHHC3-dependent palmitoylation of RGS4.were transfected with RGS4C2S, RGS4 or RGS4 and DHHC3, cultured under hypoxia
idation-induced degradation of pre-accumulated RGS4 or its mutant was examined
RGS4 degradation. (B). Time-course of RGS4 degradation obtained from three
ical density units in each group were set as 1. Points, mean; bars, S.E.
n. HEK293 cells stably expressing a1A-AR were loaded with Fluo-4. Elevations in
ce vs. maximum ﬂuorescence in the presence of A23187 (2 lM). (A) Phenylephrine
= 4). (B) Co-expression of RGS4 with DHHC3 attenuated phenylephrine-stimulated
4574 J. Wang et al. / FEBS Letters 584 (2010) 4570–45743.4. DHHC3-dependent palmitoylation protects RGS4 from proteasome
degradation
We next determined if increased RGS4 protein levels seen with
palmitoylation were due to prolongation of RGS4 half-life. HEK293
cells with hypoxia-induced RGS4 accumulation were transferred to
normoxia in the presence of cycloheximide to block new protein
synthesis. The disappearance of pre-accumulated RGS4 was then
followed over time by Western blot. Fig. 4A shows a representative
Western blot indicating that RGS4 was degraded rapidly and that
MG132 blocked degradation. In contrast, degradation of oxida-
tion-resistant RGS4C2S mutant is much slower. Interestingly, co-
expression of DHHC3 slowed the degradation rate of RGS4. RGS4
had a half-life of approximately 30 min while the half-lives of
RGS4C2S mutant and RGS4 that was palmitoylated by DHHC3 ex-
ceeded 4 h (Fig. 4B). Thus, DHHC3-dependent palmitoylation pro-
tects RGS4 from proteasome degradation and extends its half-life
by over 8-fold.
3.5. Palmitoylated RGS4 attenuates a1A-AR-dependent intracellular
Ca2+ mobilization
a1A-AR predominantly couple to Gq-mediated phosphoinositide
hydrolysis pathways which mobilize intracellular Ca2+ [18]. As
shown in Fig. 5A, in HEK293 cells stably expressing a1A-AR, the
a1A-AR agonist phenylephrine caused a transient increase in the
Ca2+ indicator Fluo-4 ﬂuorescence that lasted approximately
1 min. Phenylephrine increased intracellular Ca2+ in a concentra-
tion-dependent manner (Fig. 5A, inset) with an EC50 of
77 ± 15 nM. The a1-AR antagonist prazosin blocked phenyleph-
rine-stimulated Ca2+ mobilization. Expression of RGS4 alone had
little effect, presumably due to rapid degradation of expressed
RGS4 protein. In contrast, co-transfection of RGS4 with DHHC3 re-
sulted in 60% reduction of phenylephrine-stimulated intracellular
Ca2+ as compared to cells expressing DHHC3 alone (Fig. 5B). Thus,
palmitoylated RGS4 protein can attenuate a1A-AR dependent Ca2+
mobilization in vivo.
4. Conclusion
We conﬁrmed that RGS4 protein levels are regulated by the N-
end rule for proteasomal degradation via a Cys2-dependent oxida-
tion of RGS4 [6–9]. In addition, our study provides the ﬁrst evidence
that RGS4 is palmitoylated by DHHC3 and DHHC7 acyltransferases
in vivo and that Cys2 of RGS4 is essential for this palmitoylation.
Palmitoylation usually increases protein afﬁnity for cellmembranes
as a possible regulatory mechanism. However, palmitoylation of
RGS4 is not required for its attachment to the plasma membrane
[19]. We demonstrated that the palmitoylation of RGS4 in vivo pro-
longs RGS4 half-life by interfering with its oxidation-dependent
degradation, and that this palmitoylated RGS4 can attenuate func-
tions of GPCRs such as a1A-AR in cells. Thus, the present ﬁndings
revealed a novel mechanism bywhich DHHC acyltransferase-medi-
atedproteinpalmitoylation.Moreover, our data raise the interesting
possibility that in addition to controllingG-protein localization [13],
DHHCs may also modulate GPCR signaling events through regula-
tion of RGS4 stability.Acknowledgements
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